CIK 0001739174 · Non-accelerated filer<br>Smaller reporting company
Tessera Defense & Homeland Security Inc.
Sign in to watch- Ticker
- HLSQ
- Exchange
- NYSE
- Industry
- Services-Prepackaged Software
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 823364020
- Phone
- 972 545610935
- Business address
- 850 NEW BURTON ROAD, SUITE 201, DOVER, DE, 19904
- Former names
- BiomX Inc., Chardan Healthcare Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-11 | Solomon Jonathan Eitan Chief Executive Officer | Returned to the company · Common Stock Options - Right to Buy | −205,000 | 0 | ||
| 2023-12-11 | Solomon Jonathan Eitan Chief Executive Officer | Grant or award · Common Stock Options - Right to Buy | +146,429 | 146,429 | ||
| 2023-12-11 | Oron Assaf Chief Business Officer | Returned to the company · Common Stock Options - Right to Buy | −31,500 | 0 | ||
| 2023-12-11 | Oron Assaf Chief Business Officer | Grant or award · Common Stock Options - Right to Buy | +8,290 | 8,290 | ||
| 2023-12-11 | Oron Assaf Chief Business Officer | Returned to the company · Common Stock Options - Right to Buy | −33,250 | 0 | ||
| 2023-12-11 | Oron Assaf Chief Business Officer | Grant or award · Common Stock Options - Right to Buy | +8,750 | 8,750 | ||
| 2023-11-29 | Oron Assaf Chief Business Officer | Sale | −5,444 | $0.40 | $2K | 5,470 |
| 2023-11-29 | Oron Assaf Chief Business Officer | Sale | −3,414 | $0.35 | $1K | 2,056 |
| 2023-11-29 | Oron Assaf Chief Business Officer | Sale | −2,056 | $0.34 | $699 | 0 |
| 2023-10-29 | Bassan Merav Chief Development Officer | Returned to the company · Common Stock Options - Right to Buy | −189,997 | 0 | ||
| 2023-10-29 | Bassan Merav Chief Development Officer | Grant or award · Common Stock Options - Right to Buy | +189,997 | 0 | ||
| 2023-10-29 | Wolfson Marina Chief Financial Officer | Grant or award · Common Stock Options - Right to Buy | +59,800 | 59,800 | ||
| 2023-10-29 | Solomon Jonathan Eitan Chief Executive Officer | Returned to the company · Common Stock Options - Right to Buy | −182,133 | 0 | ||
| 2023-10-29 | Solomon Jonathan Eitan Chief Executive Officer | Grant or award · Common Stock Options - Right to Buy | +182,133 | 0 | ||
| 2023-10-29 | Solomon Jonathan Eitan Chief Executive Officer | Returned to the company · Common Stock Options - Right to Buy | −201,708 | 0 | ||
| 2023-10-29 | Solomon Jonathan Eitan Chief Executive Officer | Grant or award · Common Stock Options - Right to Buy | +201,708 | 0 | ||
| 2023-10-29 | Solomon Jonathan Eitan Chief Executive Officer | Returned to the company · Common Stock Options - Right to Buy | −284,701 | 0 | ||
| 2023-10-29 | Solomon Jonathan Eitan Chief Executive Officer | Grant or award · Common Stock Options - Right to Buy | +284,701 | 0 | ||
| 2023-10-29 | Oron Assaf Chief Business Officer | Returned to the company · Common Stock Options - Right to Buy | −155,363 | 0 | ||
| 2023-10-29 | Oron Assaf Chief Business Officer | Grant or award · Common Stock Options - Right to Buy | +155,363 | 0 |
Page 6 of 12 · 240 trades